Royal Palms Capital’s Merck MRK Stock Holding History

Royal Palms Capital’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$663K	Buy	5,158 +28	+0.5%	+$3.28K	0.58%	35
2026 Q1	$617K	Buy	+5,130	New	+$592K	0.61%	34

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Royal Palms Capital's MRK Position: Q2 2026 in Review

Royal Palms Capital increased its Merck (MRK) stake by 0.55% in Q2 2026, buying an estimated $3.28K and bringing the position to 5,158 shares worth $663K. The position accounts for 0.58% of the portfolio, ranked #35.

Royal Palms Capital first reported a position in MRK in Q1 2026 and has held it in 2 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Royal Palms Capital held 5,158 shares of Merck worth $663K as of Q2 2026.
Royal Palms Capital bought 28 Merck shares in Q2 2026, an estimated $3.28K.
Merck made up 0.58% of Royal Palms Capital's portfolio in Q2 2026, its #35 holding.
Royal Palms Capital first reported a position in Merck in Q1 2026 and has held it in 2 quarters since.
3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Royal Palms Capital's 13F filing for Q2 2026, filed 7 Aug 2026.